[Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?]

Rev Med Interne. 1999 May;20(5):397-9. doi: 10.1016/s0248-8663(99)83089-6.
[Article in French]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use*
  • Cerebrovascular Disorders / prevention & control*
  • Dipyridamole / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Ischemic Attack, Transient / drug therapy*
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents / therapeutic use*

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
  • Dipyridamole
  • Aspirin